105 related articles for article (PubMed ID: 1872924)
21. Smoking-induced alterations in platelet membrane fluidity and Na(+)/K(+)-ATPase activity in chronic cigarette smokers.
Padmavathi P; Reddy VD; Maturu P; Varadacharyulu N
J Atheroscler Thromb; 2010 Jun; 17(6):619-27. PubMed ID: 20154447
[TBL] [Abstract][Full Text] [Related]
22. [Incorporation of 1-0-alkyl-2-acetyl-sn-glycerol-3-phosphocholine into human plasma lipoproteins in vitro. Effect of the lecithin:cholesterol acyltransferase activity of plasma].
Kulikov VI; Muzia GI; Bergel'son LD
Biokhimiia; 1984 Sep; 49(9):1449-55. PubMed ID: 6542803
[TBL] [Abstract][Full Text] [Related]
23. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum.
Ostermann G; Kostner GM; Gries A; Malle E; Till U
Haemostasis; 1989; 19(3):160-8. PubMed ID: 2744632
[TBL] [Abstract][Full Text] [Related]
24. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.
Heery JM; Kozak M; Stafforini DM; Jones DA; Zimmerman GA; McIntyre TM; Prescott SM
J Clin Invest; 1995 Nov; 96(5):2322-30. PubMed ID: 7593619
[TBL] [Abstract][Full Text] [Related]
25. Platelet activating factor: an inhibitor of neutrophil activation?
O'Donnell MC; Siegel JN; Fiedel BA
Clin Exp Immunol; 1981 Jan; 43(1):135-42. PubMed ID: 7249391
[TBL] [Abstract][Full Text] [Related]
26. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
27. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.
Craig WY; Palomaki GE; Haddow JE
BMJ; 1989 Mar; 298(6676):784-8. PubMed ID: 2496857
[TBL] [Abstract][Full Text] [Related]
28. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
29. Lipid inhibitors of platelet-activating factor (PAF) in normal human plasma.
Woodard DS; Ostrom KK; McManus LM
J Lipid Mediat Cell Signal; 1995 Jul; 12(1):11-28. PubMed ID: 7551686
[TBL] [Abstract][Full Text] [Related]
30. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
Noto H; Hara M; Karasawa K; Iso-O N; Satoh H; Togo M; Hashimoto Y; Yamada Y; Kosaka T; Kawamura M; Kimura S; Tsukamoto K
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):829-35. PubMed ID: 12649088
[TBL] [Abstract][Full Text] [Related]
31. Presence of paf-acether in human blood after thin-layer chromatography, but not after high-performance liquid chromatography purification.
Izzo AA; Benveniste J
J Pharmacol Toxicol Methods; 1996 Dec; 36(4):219-21. PubMed ID: 9040113
[TBL] [Abstract][Full Text] [Related]
32. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
[TBL] [Abstract][Full Text] [Related]
33. Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity.
Tambaki AP; Rizos E; Tsimihodimos V; Tselepis AD; Elisaf M
J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):91-5. PubMed ID: 15309245
[TBL] [Abstract][Full Text] [Related]
34. Plasma lipid and lipoprotein profiles of cigarette smokers from randomly selected families: enhancement of hyperlipidemia and depression of high-density lipoprotein.
Brischetto CS; Connor WE; Connor SL; Matarazzo JD
Am J Cardiol; 1983 Oct; 52(7):675-80. PubMed ID: 6624657
[TBL] [Abstract][Full Text] [Related]
35. The detection of platelet-activating factor in inflamed human gingival tissue.
Noguchi K; Morita I; Murota S
Arch Oral Biol; 1989; 34(1):37-41. PubMed ID: 2783040
[TBL] [Abstract][Full Text] [Related]
36. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
O'Flaherty JT
J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
[TBL] [Abstract][Full Text] [Related]
37. Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis.
Tokumura A; Sumida T; Toujima M; Kogure K; Fukuzawa K
Biofactors; 2000; 13(1-4):29-33. PubMed ID: 11237195
[TBL] [Abstract][Full Text] [Related]
38. Influence of smoking, body fat distribution, and alcohol consumption on serum lipids, lipoproteins, and apolipoproteins in early postmenopausal women.
Haarbo J; Hassager C; Schlemmer A; Christiansen C
Atherosclerosis; 1990 Oct; 84(2-3):239-44. PubMed ID: 2282102
[TBL] [Abstract][Full Text] [Related]
39. Alcohol intake, cigarette smoking and plasma lipids and lipoproteins in 12--19-year-old children. The Collaborative Lipid Research Clinics Prevalence Study.
Glueck CJ; Heiss G; Morrison JA; Khoury P; Moore M
Circulation; 1981 Sep; 64(3 Pt 2):III 48-56. PubMed ID: 7020984
[TBL] [Abstract][Full Text] [Related]
40. The insulin resistance syndrome and postprandial lipid intolerance in smokers.
Eliasson B; Mero N; Taskinen MR; Smith U
Atherosclerosis; 1997 Feb; 129(1):79-88. PubMed ID: 9069521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
